我院2006-2011年药品应用情况分析  

Analysis of Drug Use in Our Hospital during 2006-2011

作　　者：丁建强[1] 吴爱京[2] 朱军[1] 胡倩[1] 

机构地区：[1]武警河南总队医院药剂科,郑州450052 [2]武警河南总队医院经管科,郑州450052

出　　处：《中国药房》2012年第26期2416-2419,共4页China Pharmacy

摘　　要：目的:了解我院2006-2011年的药品应用情况,总结我院控制药品费用占医疗总收入比例(简称"药占比")的经验和方法。方法:采用回顾性方法,对我院2006-2011年药占比情况进行统计、分析,并与全国平均药占比进行比较。结果:我院各年度各类患者药占比均低于30%,低于全国各年度平均水平,但呈逐年增高趋势;省、市、铁路"医保"患者药占比上升趋势明显;2010-2011年军队"医改"类患者药占比明显低于前4年。结论:药品价格和用量是导致我院药占比明显上升的2个关键因素。改革医疗体制和药品定价机制中的不合理问题,主动采取合理有效的监管和干预措施,实行临床路径管理,推行单病种收费,制订各科药占比控制目标,加强医疗专业素质培训等控制药品的价格和用量,从而有效控制药占比的做法是可行的。OBJECTIVE： To investigate the drug use of our hospital during 2006-2011, and to summarize the experience of controlling the proportion of drug cost in total medical income （called ＂drug cost ratio＂ in short） in our hospital. METHODS： By retrospective method, drug cost ratio of our hospital during 2006-2011 was analyzed statistically, and compared with national average drug cost ratio. RESULTS： The drug cost ratios of various drugs in our hospital were all below 30%, which was lower than national value, but showed an increasing tendency in recent years. The drug cost ratio of patients with provincial, municipal or rail- way medical insurance significantly increased. During 2010-2011, the drug cost ratio of military patients was markedly lower than the past 4 years. CONCLUSIONS： Drug price and amount are 2 major factors of the increase of drug cost ratio in our hospital. It is supposed to reform medical system and drug pricing mechanism, carry out effective and rational monitoring and intervention measures, take clinical pathway and price charge for single disease, set goals of controlling drug cost ratio for different departments, strengthen medical professional training. From what has been discussed above, the price and amount of drugs can be controlled. In this way, it is feasible to control drug cost ratio.

关 键 词：药品价格 药品数量 药占比 用药分析 干预 

分 类 号：R969.3[医药卫生—药理学] R287[医药卫生—药学]